Global M&A activity so far this year is at its highest level since the financial crisis, expert analysis has revealed.
Some $705bn of deals have been announced since the start of 2017, the first time the $700bn barrier has been broken since 2007, according to Dealogic.
US group Johnson & Johnson’s $31.4bn bid for Swiss pharmaceuticals firm Actelion is 2017's largest deal to date and due to close in April. The purchase will be Johnson & Johnson's largest on record.
Morgan Stanley was top of the adviser charts. Although its share of total deals fell from 22.0 per cent to 20.2 per cent, it was involved in $142.7bn of deals well ahead of second-placed Baml with $130.3bn.
Goldman Sachs, which was top of the pile this time last year, advising on nearly a third of deals, fell to fourth place. Its share near-halved to 16.7 per cent having been engaged on $118.2bn of transactions.
Oil and gas dominated from a sectorial perspective with $96.7bn of deals agreed, at a highest ever year to date level. $52.4bn of these deals were in the domestic sectors of the US and Canada.
Healthcare came a narrow second, with a total of $95.9bn transactions were announced, while technology was in third spot with $87.1bn of deals. Intel’s $15.4bn bid for Mobileye, is the largest tech transaction the largest Israeli targeted firm.